Monday Memo (On A Tuesday)
A Byte of Knowledge
The comments under your ads are buyers telling you, in their own words, what they want and what's stopping them.
And AI can scrape all of it and hand you new hooks by lunch.
That's powerful, except now you're learning your market through a translator.
Because you get the meaning every time and never pick up the language.
Read them yourself, though, and the language sticks: the exact words a buyer uses for her belly fat, the odd object she keeps mentioning that would make a killer static.
None of that survives a summary.
A marketer on a recent training of ours calls it "priming your brain," which is why they still read comments by hand.
So do both.
Let the model scrape and spin its variations, then read the same comments yourself anyway.
The model reading them gets you this month's ads.
And you reading them keeps your taste sharp.
π WATCH: How These AI Copy Bots Are Producing World-Class Sales Copy 50X Faster Than Even The "BEST" Copywriters On The Marketβ¦
(Plus⦠They Don't Get Sick, Miss Deadlines, Or Ask For Raises Either!)
Watch the full AI Copywriting Tell-All Video Here
Something to Ponder

We Asked β AI Answered
Our Question:
"Weβve seen a huge rise in telehealth companies offering prescription drugs online... from GLP-1s and testosterone to antidepressants.
How high is the barrier to entry for the average online entrepreneur to start a business like this? Is getting into prescription drugs as difficult as youβd assume?"
AI's Answer: The Hardest Part Costs About $8,000 π
Your intuition says prescription drugs mean FDA, DEA, and medical boards standing in the doorway. The actual doorway has a vendor invoice taped to it.
ποΈ The Clinical Layer Is Rentable
You never see a patient. You never write a script. You rent both.
The infrastructure bench:
β OpenLoop
β Wheel
β SteadyMD
β MD Integrations
Each one supplies licensed clinicians across all 50 states, e-prescribing, EHR, credentialing, malpractice coverage, and mail-order pharmacy fulfillment... behind your logo.
Turnkey pricing on public pages: $2,500 to $8,000 setup, $250 to $1,000 monthly. Live in 30 to 60 days.
βοΈ The Ownership Puzzle Was Solved Decades Ago
Most states enforce the Corporate Practice of Medicine doctrine. A layperson can't own a company that practices medicine.
Lawyers built the workaround a long time ago, and it's completely legal:
You Own:
- The MSO: brand, funnel, tech, data
- Collects a management fee
A Physician Owns:
- The professional corporation
- Employs the clinicians

πͺ Your Real Gatekeepers Are Ad Platforms and Card Networks
β LegitScript Healthcare Merchant Certification ... $975 to apply, roughly $2,150 annually, per website
β Google, Meta, Bing, TikTok, and LinkedIn all demand it before your ads run
β Visa and Mastercard want it for card-not-present telemedicine
β Testosterone sits in Schedule III, still prescribable by video with no in-person exam under DEA flexibilities extended through December 31, 2026
β GLP-1s aren't controlled substances at all

β° The Trapdoor Not Priced In
Compounded semaglutide was legal only because FDA listed the drug as in shortage. Then FDA closed the listing:
- February 2025 ... shortage declared resolved
- April 22, 2025 ... 503A pharmacies must stop compounding it
- May 22, 2025 ... 503B outsourcing facilities must stop
Thousands of operators lost their hero product on a date they had no vote on. Tirzepatide sellers got hit weeks earlier.
Enforcement receipts:
π¨ FTC ordered Cerebral to pay $7 million in 2024 over health-data sharing and cancellation dark patterns
π¨ DOJ charged Done Global's CEO and clinical president in 2024 with conspiring to distribute Adderall through their telehealth funnel
π¨ California's SB 351 took effect January 1, 2026, tightening who may control clinical decisions
π― The Straight Answer
Entry is cheap. A competent operator with roughly $25k and a healthcare attorney can be taking orders in two months.
What you're actually signing up for: regulatory exposure on a molecule you don't manufacture, with a supply chain that answers to federal agencies, plus personal liability the moment your intake form starts approving patients faster than a clinician can honestly evaluate them.
The pill isn't the moat. Your tolerance for waking up to a Federal Register notice is. π

Thanks for reading the Monday Memo.
Until next time!
The AI Marketers
P.S. Help shape the future of this newsletter β take a short 2-minute survey so we can deliver even better AI marketing insights, prompts, and tools.
[Take Survey Here]
